Symposium “The Epitranscriptome in Cancer and Autoimmunity”
The epitranscriptome, encompassing the full range of chemical RNA modifications, is emerging as a major layer of gene expression regulation. By modulating RNA stability, translation, and localization, these dynamic marks play key roles in immune responses, inflammation, and cellular homeostasis. Their dysregulation is increasingly linked to cancer and autoimmune diseases, opening new diagnostic and therapeutic opportunities.
Program :
3:00-3:40 PM Trageting RNA modifications in cancer
Prof. Dr. Michaela FRYE
3:40-4:00 PM Discovery of a tRNA-regulatory transcription factor that suppresses breast cancer metastasis
Dr. Albertas NAVICKAS
4:00-4:30 PM Coffee break
4:30-5:00 PM Epitranscriptomics in autoimmunity: where we are and where we are going
Dr. Rami BECHARA
5:00-5:20 PM Illuminating autoimmune diseases through epitranscriptome: insights from rheumatoid arthritis
Dr. Mar NARANJO-GOMEZ
5:20 PM Closing remarks
salle 1 batiment rechercheThe epitranscriptome, encompassing the full range of chemical RNA modifications, is emerging as a major layer of gene expression regulation. By modulating RNA stability, translation, and localization, these dynamic marks play key roles in immune responses, inflammation, and cellular homeostasis. Their dysregulation is increasingly linked to cancer and autoimmune diseases, opening new diagnostic and therapeutic opportunities.
Program :
3:00-3:40 PM Trageting RNA modifications in cancer
Prof. Dr. Michaela FRYE
3:40-4:00 PM Discovery of a tRNA-regulatory transcription factor that suppresses breast cancer metastasis
Dr. Albertas NAVICKAS
4:00-4:30 PM Coffee break
4:30-5:00 PM Epitranscriptomics in autoimmunity: where we are and where we are going
Dr. Rami BECHARA
5:00-5:20 PM Illuminating autoimmune diseases through epitranscriptome: insights from rheumatoid arthritis
Dr. Mar NARANJO-GOMEZ
5:20 PM Closing remarks